Page 58 - 22-0424

The International Journal of the Royal Society of Thailand
Volume XI - 2019

Fukuoka M, Wu Y, Thongprasert S, Sunpaweravong P, Leong S, Sriuranpong
V et al. Biomarker analyses and final overall survival results from a phase
III, randomized, open-label, first-line study of gefitinib versus carboplatin/

paclitaxel in clinically selected patients with advanced non–small-cell
lung cancer in Asia (IPASS). J Clin Oncol. 2011;29(21):2866–2874. doi:10.1200/
jco.2010.33.4235.

Guinney J, Dienstmann R, Wang X, de Reyniès A, Schlicker A, Soneson C et al.
The consensus molecular subtypes of colorectal cancer. Nat Med.
2015;21(11):1350–1356. https://doi.org/10.1038/nm.3967.
Kim H and Choi D. Distribution ofBRCA1and BRCA2 mutations in Asian patients
with breast cancer. J Breast Cancer. 2013;16:357–365. doi:10.4048/jbc.2013.
16.4.357.

Korphaisarn K, Pongpaibul A, Roothumnong E, Pongsuktavorn K, Thamlikitkul
L, Anekpuritanang T et al. High Frequency of KRAS Codon 146 and FBXW7

Mutations in Thai Patients with Stage II-III Colon Cancer. Asian Pac J
Cancer Prev. 2019;20:2319–2326. doi:10.31557/apjcp.2019.20.8.2319.
Korphaisarn K, Lam M, Loree J, Ruiz E, Aguiar S, Kopetz S. Consensus molecular
subtypes in colorectal cancer differ by geographic region. J Clin Oncol.
2020;38:4061–4061. doi:10.1200/jco.2020.38.15_suppl.4061.

Meng H, Guo X, Sun D, Liang Y, Lang J, Han Y et al. Genomic profiling of driver
gene mutations in Chinese patients with non-small cell lung cancer. Front
Genet. 2019;10:1008. doi:10.3389/fgene.2019.01008.

Mok T, Wu Y, Thongprasert S, Yang C, Chu D, Saijo N et al. Gefitinib or
carboplatin–paclitaxel in pulmonary adenocarcinoma. N Engl J Med.
2009;361(10):947–957. doi:10.1056/nejmoa0810699.

Niyomnaitham S, Parinyanitikul N, Roothumnong E, Jinda W, Samarnthai N,
Atikankul T et al. Tumor mutational profile of triple negative breast cancer
patients in Thailand revealed distinctive genetic alteration in chromatin
remodeling gene. PeerJ. 2019;7:e6501. doi:10.7717/peerj.6501.

Ragulan C, Eason K, Fontana E, Nyamundanda G, Tarazona N, Patil Y et al.
Analytical validation of multiplex biomarker assay to stratify colorectal
cancer into molecular subtypes. Sci Rep. 2019;9(1):7665. doi:10.1038/s41598-
019-43492-0.

52 Cancer Precision Medicine and Ethnic Diversity

11/7/2565 BE 13:27
_22-0424(047-054)6.indd 52
_22-0424(047-054)6.indd 52 11/7/2565 BE 13:27